Methylprednisolone Unknown Status Phase 3 Trials for Chronic Lymphocytic Leukaemia (CLL) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01670812Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia